Signatures Of TSPAN8 Variants Associated With Human Metabolic Regulation And Diseases
Tisham DeiD, Ângela GonçalvesiD, Doug SpeediD, Philippe FrogueliD, Daniel J. GaffneyiD, Michael R. JohnsoniD, Marjo‐Riitta JärveliniD, Lachlan CoiniD
Abstract
Here, with the example of common copy number variation (CNV) in the TSPAN8 gene, we present an important piece of work in the field of CNV detection, CNV association with complex human traits such as 1H NMR metabolomic phenotypes and an example of functional characterization of CNVs among human induced pluripotent stem cells (HipSci). We report TSPAN8 exon 11 as a new locus associated with metabolomic regulation and show that its biology is associated with several metabolic diseases such as type 2 diabetes (T2D), obesity and cancer. Our results further demonstrate the power of multivariate association models over univariate methods and define new metabolomic signatures for several new genomic loci, which can act as a catalyst for new diagnostics and therapeutic approaches.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 9
- FWCI
- 0.85
- Field percentile
- top 30%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Functional dissection of metabolic trait-associated gene regulation in steady state and stimulated human skeletal muscle cells
Kirsten Nishino, Gabriella Bloss, … Adelaide Tovar·bioRxiv·Nov 28, 2024
- Altered Hepatic Metabolism in Down Syndrome
Lauren N. Dunn, Brian F. Niemeyer, … Kelly D. Sullivan·Cell ReportsPeer-reviewed·Jan 1, 2026
- CARDIOVASCULAR AUTONOMIC NEUROPATHY IN TYPE 1 DIABETES IS ASSOCIATED WITH SEVERAL METABOLIC PATHWAYS: New Risk Markers on the horizon
Christian Stevns Hansen, Tommi Suvitaival, … Tarunveer S. Ahluwalia·bioRxiv·May 18, 2021
- Context dependent perturbation of allelic expression imbalance reveals novel candidate therapeutic targets for metabolic diseases
Sunjin Moon, So‐Young Park·bioRxiv·Nov 6, 2023
- Insights into the metabolic consequences of type 2 diabetes
Ozvan Bocher, Archit Singh, … Eleftheria Zeggini·bioRxiv·Jun 20, 2024
- Cross-platform genetic discovery of small molecule products of metabolism and application to clinical outcomes
Luca Andrea Lotta, Maik Pietzner, … Claudia Langenberg·bioRxiv·Feb 3, 2020